PACB   $1.33  -5.00% Market Closed After Close 1.35 1.50%

Pacific Biosciences of California, Inc.
Total Cash 509.80M
totalCashPerShare 1.871
EBITDA -267.69M
Total Debt 924.95M
quickRatio 6.917
currentRatio 8.013
Total Revenue 188.87M
debtToEquity 187.731
Revenue/Share 0.71
ROA -0.11238
ROE -0.70571
grossProfits
freeCashflow -297.27M
operatingCashflow -252.69M
earningsGrowth
revenueGrowth -0.243
grossMargins 0.31405002
ebitdaMargins -1.4173399
operatingMargins -1.76736
profitMargins -2.11988
enterpriseValue 1.11B
forwardPE -3.5808823
floatShares 270.87M
sharesOutstanding 272.53M
sharesShort 48.54M
sharesShortPriorMonth 46.53M
dateShortInterest
sharesPercentSharesOut 0.18%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.82%
Short Ratio help_outline 5.67%
shortPercentOfFloat 0.21%
impliedSharesOutstanding
bookValue 1.808
Price To Book help_outline 1.35
earningsQuarterlyGrowth
netIncomeToCommon -400.38M
trailingEps -1.50%
forwardEps -0.68%
enterpriseToEbitda -4.15
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.22 3Q 2024
institutionsCount 313
lastUpdated Nov. 6, 2024, 7:22 p.m.